Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
about
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
description
scientific article published on 30 March 2020
@en
name
Inhibition of SARS-CoV-2 (prev ...... ity to mediate membrane fusion
@en
type
label
Inhibition of SARS-CoV-2 (prev ...... ity to mediate membrane fusion
@en
prefLabel
Inhibition of SARS-CoV-2 (prev ...... ity to mediate membrane fusion
@en
P2093
P50
P1433
P1476
Inhibition of SARS-CoV-2 (prev ...... ity to mediate membrane fusion
@en
P2093
Lanying Du
Linlin Bao
Meiqin Liu
Shibo Jiang
Shuwen Liu
Siliang Feng
P304
P356
10.1038/S41422-020-0305-X
P577
2020-03-30T00:00:00Z
P6179
1126001889
P698
P8150
covidwho-30393